CXCR3 and neoplasm: The observation that CD26 is upregulated on activated T cells could be a regulatory feedback mechanism to limit CXCR3+ lymphocyte infiltration, which is favorable in an inflammatory setting where the pro-inflammatory response has to be dampened, but unfavorable in a tumor setting where the host’s immune defense has to be sustained [168,229].